Clinical Trial Update: A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome [Phase 1]

View source ↗

Summary

Phase 1 study evaluating continuous intravenous L-citrulline during sickle cell pain crisis or acute chest syndrome; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-citrulline (continuous intravenous administration) (L-citrulline)

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-04-17